Countries covered: Global
Cardiovascular Drugs: Global Markets & Developments
Due to the continuing strong demand for antihyperlipidemics, adrenergic blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor antagonists, anticoagulants and antiplatelet agents, the total worldwide cardiovascular market is expected to show revenues of $91.2 billion in 2008, an increase of 6.9% compared with 2003.
Focusing on the new and emerging products that will affect this market in the future, Theta’s report provides provides a detailed analyses of the market’s composition and dynamics. Manufacturer’s market share, demographics, and the impact of changing health coverage are all examined.
The cardiovascular diseases covered in the report include:
·Angina
·Arrhythmia
·Atherosclerosis
·Congestive heart failure
·Coronary artery disease
·Hypertension
·Myocardial infarction
The report covers the following drug classes:
·Adrenergic blockers
·Adrenergic stimulators
·Angiotensin converting enzyme iInhibitor
·Angiotensin II receptors antagonists
·Antidysrhythmics
·Antihyperlipidemics
·Antilipiemics
·Thrombolytics
·Calcium channel blockers
·Diuretics
·Glycosides
·Vasodilators
·Vasopressors
·Antilplatelet agents
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Related Reports:
Snapshots US Pharmaceuticals 2009
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Pharmaceuticals Industry Report
Pharmaceutical Industry in Mexico
Antipsychotics Market Forecast
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Antidepressants Market Forecast
Snapshots Australia Pharmaceuticals 2009
Snapshots Bulgaria Pharmaceuticals 2009
|
(0 items)
